EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Five‑fraction stereotactic body radiotherapy for prostate cancer in octogenarians and nonagenarians: A single‑institution retrospective cohort study

Atsuto Katano, Hideomi Yamashita

Oncology Letters · 22.10.2026 · 32 (6) · 1-8

DOI: 10.3892/ol.2026.15917 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Oncology Letters, online erschienen am 22.10.2026. Verfasst von Atsuto Katano und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The University of Tokyo Hospital, Tokyo 113-8655, Japan. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incidence of prostate adenocarcinoma (PCa) increases with age. Stereotactic body radiotherapy (SBRT) is a curative option; however, the evidence in elderly patients remains limited. This single-institution retrospective cohort study included consecutive patients aged ≥80 years with localized PCa treated with definitive SBRT between May 2016 and June 2023. SBRT was delivered in five fractions with a total dose of 36.25-45.00 Gy. A total of 118 patients with a median age of 82 years (range, 80-93 years) were included. Risk stratification identified three low-risk, 15 favorable intermediate-risk, 32 unfavorable intermediate-risk, 48 high-risk and 20 very high-risk patients. With a median follow-up of 47.7 months, there were seven deaths from any cause and nine biochemical recurrences, with no PCa-related deaths observed. The 3- and 5-year overall survival rates were 99.1 and 94.2%, respectively, whereas the 3- and 5-year biochemical progression-free survival rates were 94.5 and 83.2%, respectively. No acute genitourinary or gastrointestinal toxicities of grade 3 or higher were observed. Late grade 3 genitourinary and gastrointestinal toxicities were each observed in three patients, with no grade higher than 3 events. Definitive prostate SBRT achieved favorable survival outcomes with acceptable toxicity in carefully selected octogenarians and nonagenarians, supporting its feasibility as a curative-intent treatment option in this elderly population.

Schlagwörter

Stichwörter der Autor:innen

elderlyoctogenarianprostate cancerstereotactic body radiotherapysurvivaltoxicityultra-hypofractionation

Autor:innen und Institutionen

  • Department of Radiology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.

Zitieren

APA

Katano, A., & Yamashita, H. (2026). Five‑fraction stereotactic body radiotherapy for prostate cancer in octogenarians and nonagenarians: A single‑institution retrospective cohort study. Oncology Letters, 32(6), 1-8. https://doi.org/10.3892/ol.2026.15917

Vancouver

Katano A, Yamashita H. Five‑fraction stereotactic body radiotherapy for prostate cancer in octogenarians and nonagenarians: A single‑institution retrospective cohort study. Oncology Letters. 2026;32(6):1-8. doi:10.3892/ol.2026.15917

BibTeX
@article{Katano2026,
  author = {Katano, Atsuto and Yamashita, Hideomi},
  title = {Five‑fraction stereotactic body radiotherapy for prostate cancer in octogenarians and nonagenarians: A single‑institution retrospective cohort study},
  journal = {Oncology Letters},
  year = {2026},
  volume = {32},
  number = {6},
  pages = {1--8},
  doi = {10.3892/ol.2026.15917}
}
Kostenlos starten →